AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
A genomics company, a crypto foundation, and the former CEO are all looking at this treasure trove of genetic data.
Californian and NY Times columnist draws major buzz for “Abundance,” a new book about how Democrats can boost their fortunes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback